Assistant Professor
Research Interests:

heart failure; cardiac resynchronization therapy; chronic obstructive pulmonary disease; epidemiology, remote monitoring

Research Summary:

My research is focused on improving quality of life and outcomes for patients with heart failure, by addressing comorbidities, using implantable and external devices, remote monitoring, and improving systems of care. I have 61 peer-reviewed publications (23 as 1st, 10 as 2nd, and 4 senior author), h-index 24.


I am Assistant Professor at UBC and holder of the Dr. Charles Kerr Distinguished Scholar in Heart Rhythm Management. I completed my Doctorate of Medicine research degree at Glasgow University, focused on the intersection between heart failure and chronic obstructive pulmonary disease. I moved to Liverpool for cardiology and fellowship training in Europe’s highest volume device centre, focusing on pacing and cardiac resynchronization therapy. There I completed a Masters of Public Health focusing on the epidemiology of cardiovascular disease, population modelling, and health systems.

This dual training and certification in Heart Function and Heart Rhythm management provides an innovative perspective on integration of technology with chronic disease management. I am currently Physician Lead for the Regional Heart Failure Program in Vancouver Costal Health and Physician Advisor for the provincial remote monitoring and heart failure strategies at Cardiac Services BC.

I have presented at numerous national and international conferences on the subject of cardiovascular disease in COPD (including British Cardiac Society and European Society of Cardiology). I authored the Oxford Handbook of Heart Failure chapter addressing concurrent lung disease, and the ESC Textbook of Cardiovascular Medicine 3rd edition chapter on Lung disease. My work is referenced in international HF guidelines, and I am currently participating in a Lancet Global Commission on COPD.

Post-doctorate, Fellowship Heart Ryhthm Therapy, Electrophysiology, University of British Columbia
Post-doctorate, Fellowship Advanced Heart Failure and Transplant, Heart Failure, University of British Columbia
Post-doctorate, Fellowship Heart Rhythm Device Therapy, Electrophysiology, The University of Liverpool
Master’s Thesis, Master in Public Health, Public Health, The University of Liverpool
Doctorate, Doctorate of Medicine, Cardiology, University of Glasgow
Bachelor’s MBChB, Medicine, University of Edinburgh
Recent Publications:

Last 3 Years

[1] Andrade JG, MacGillivray J, Macle L, Yao RJR, Bennett M, Fordyce CB, et al. Clinical effectiveness of a systematic “pill-in-the-pocket” approach for the management of paroxysmal atrial fibrillation. Heart Rhythm. 2018;15:9-16.
[2] Osmanska J, Hawkins NM, Toma M, Ignaszewski A, Virani SA. Eligibility for cardiac resynchronization therapy in patients hospitalized with heart failure. ESC Heart Fail. 2018;5:668-74.
[3] Malhi N, Hawkins NM, Andrade JG, Krahn AD, Deyell MW. Catheter ablation of atrial fibrillation in heart failure with reduced ejection fraction. J Cardiovasc Electrophysiol. 2018;29:1049-58.
[4] Andrade JG, Hawkins NM, Fordyce CB, Deyell MW, Er L, Djurdjev O, et al. Variability in Non-Vitamin K Antagonist Oral Anticoagulants Dose Adjustment in Atrial Fibrillation Patients With Renal Dysfunction: The Influence of Renal Function Estimation Formulae. Can J Cardiol. 2018;34:1010-8.
[5] Janzen ML, Malhi N, Laksman ZWM, Puyat J, Krahn AD, Hawkins NM. The QT Interval in Anorexia Nervosa: A Meta-Analysis. JACC Clin Electrophysiol. 2018;4:839-41.
[6] Hawkins NM. Cardiac resynchronization therapy improves survival in selected patients with moderately impaired ejection fraction – the importance of left ventricular remodelling. Eur J Heart Fail. 2018.
[7] Roston TM, Jones K, Hawkins NM, Bos JM, Schwartz PJ, Perry F, et al. Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review. Heart Rhythm. 2018;15:1791-9.
[8] Hawkins NM, Khosla A, Virani SA, McMurray JJ, FitzGerald JM. B-type natriuretic peptides in chronic obstructive pulmonary disease: a systematic review. BMC pulmonary medicine. 2017;17:11.
[9] Hawkins NM, Grubisic M, Andrade JG, Huang F, Ding L, Gao M, et al. Long-term complications, reoperations and survival following cardioverter-defibrillator implant. Heart. 2017;104:237-43.
[10] Wong CM, Hawkins NM, Ezekowitz JA, Jhund PS, Savu A, MacDonald MR, et al. Heart Failure in Young Adults Is Associated With High Mortality: A Contemporary Population-Level Analysis. Can J Cardiol. 2017;33:1472-7.
[11] Roversi S, Hawkins NM. Time to move from prognostication to diagnosis and treatment of heart disease in acute exacerbation of COPD. Eur Respir J. 2017;49.
[12] Hawkins NM. Chronic obstructive pulmonary disease and ventricular arrhythmia – association or causation? Heart Rhythm. 2017.
[13] Hawkins NM. Chronic obstructive pulmonary disease and heart failure in Europe-further evidence of the need for integrated care. Eur J Heart Fail. 2017;20:111-3.
[14] McDonald MA, Ashley EA, Fedak PWM, Hawkins N, Januzzi JL, McMurray JJV, et al. Mind the Gap: Current Challenges and Future State of Heart Failure Care. Can J Cardiol. 2017;33:1434-49.
[15] Campbell RT, Willox GP, Jhund PS, Hawkins NM, Huang F, Petrie MC, et al. Reporting of Lost to Follow-Up and Treatment Discontinuation in Pharmacotherapy and Device Trials in Chronic Heart Failure: A Systematic Review. Circ Heart Fail. 2016;9.
[16] Sulo E, Nygard O, Vollset SE, Igland J, Sulo G, Ebbing M, et al. Coronary angiography and myocardial revascularization following the first acute myocardial infarction in Norway during 2001-2009: Analyzing time trends and educational inequalities using data from the CVDNOR project. Int J Cardiol. 2016;212:122-8.
[17] Hawkins NM, Virani SA, Sperrin M, Buchan IE, McMurray JJ, Krahn AD. Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges. Eur J Heart Fail. 2016;18:977-86.
[18] Hawkins NM, Jhund PS, Pozzi A, O’Meara E, Solomon SD, Granger CB, et al. Severity of renal impairment in patients with heart failure and atrial fibrillation: implications for non-vitamin K antagonist oral anticoagulant dose adjustment. Eur J Heart Fail. 2016;18:1162-71.
[19] Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A. Chronic Obstructive Pulmonary Disease and Cardiac Diseases: An Urgent Need for Integrated Care. Am J Respir Crit Care Med. 2016;194:1319-36.

  • 2017-2020 PI. Contemporary treatment and outcomes of atrial fibrillation. Heart and Stroke Foundation of Canada. ($150,000)
  • 2018-2021 PI Vancouver Coastal Health Research Institute (VCHRI) Clinician Scientist Award. Vancouver Coastal Health Research Institute ($300,000)
  • 2015-2019 Co-I. TEC4Home: Telehealth for Emergency-Community Continuity of Care Connectivity via Home-Telemonitoring. CIHR eHealth Innovation Partnership Program. ($749,980)